deltatrials
Completed PHASE3 INTERVENTIONAL 3-arm NCT02487563

Prospective Study of Patients With Thrombocytopenia Following HSCT

A Prospective Study of Patients With Isolated Thrombocytopenia Following Hematopoietic Stem Cell Transplantation

Sponsor: Children's Hospital of Soochow University

Conditions Hematologic Diseases Thrombocytopenia
Interventions Conventional Treatment Decitabine rhTPO
Updated 16 times since 2017 Last updated: Apr 27, 2020 Started: Oct 31, 2015 Primary completion: Apr 12, 2019 Completion: Apr 12, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02487563, this PHASE3 trial focuses on Hematologic Diseases and Thrombocytopenia and remains completed. Sponsored by Children's Hospital of Soochow University, it has been updated 16 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshot~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshot~Jun 2018 – ~Dec 2019 · 18 months · monthly snapshot~Dec 2019 – ~Jun 2020 · 6 months · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2023 · 6 months · monthly snapshot~Jul 2023 – ~Oct 2023 · 3 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Aug 2025 · 11 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Aug 2025 — Sep 2025 [monthly]

    Completed PHASE3

  3. Sep 2024 — Aug 2025 [monthly]

    Completed PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  5. Oct 2023 — Jul 2024 [monthly]

    Completed PHASE3

▶ Show 11 earlier versions

  1. Jul 2023 — Oct 2023 [monthly]

    Completed PHASE3

  2. Jan 2023 — Jul 2023 [monthly]

    Completed PHASE3

  3. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

  4. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE3

  5. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE3

  6. Jun 2020 — Jan 2021 [monthly]

    Completed PHASE3

  7. Dec 2019 — Jun 2020 [monthly]

    Completed PHASE3

    Status: Unknown Status → Completed

  8. Jun 2018 — Dec 2019 [monthly]

    Unknown Status PHASE3

  9. Sep 2017 — Jun 2018 [monthly]

    Unknown Status PHASE3

    Status: Not Yet Recruiting → Unknown Status

  10. Feb 2017 — Sep 2017 [monthly]

    Not Yet Recruiting PHASE3

  11. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Children's Hospital of Soochow University
  • Fujian Medical University Union Hospital
  • Hebei Yanda Ludaopei Hospital
  • Nanfang Hospital, Southern Medical University
  • Peking University People's Hospital
  • Qilu Hospital of Shandong University
  • Ruijin Hospital
  • The First Affiliated Hospital of Soochow University
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Data source: The First Affiliated Hospital of Soochow University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations